pleconaril has been researched along with rupintrivir in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crump, CE; Hayden, FG; Langer, T; Steindl, TM | 1 |
Feil, SC; Hamilton, S; Krippner, GY; Lin, B; Luttick, A; McConnell, DB; Morton, CJ; Nearn, R; Parker, MW; Ryan, J; Stanislawski, PC; Tucker, SP; Watson, KG | 1 |
Ha, JD; Han, SB; Jung, YK; Jung, YS; Kim, C; Kim, J; Lee, CK; Lee, JY; Neyts, J; Scheers, E; Shin, JS | 1 |
Crump, CE; Hayden, FG; Kaiser, L | 1 |
Turner, RB | 1 |
Aguayo, E; Birkus, G; Cihlar, T; Jordan, R; Lee, G; Mello, C; Rodriguez, M | 1 |
Lv, W; Wang, Y; Zhang, M; Zhang, Y | 1 |
1 review(s) available for pleconaril and rupintrivir
Article | Year |
---|---|
The treatment of rhinovirus infections: progress and potential.
Topics: 3C Viral Proteases; Antiviral Agents; Clinical Trials as Topic; Combined Modality Therapy; Common Cold; Cysteine Endopeptidases; Dietary Supplements; Drug Therapy, Combination; Echinacea; Enzyme Inhibitors; Histamine H1 Antagonists; Humans; Intercellular Adhesion Molecule-1; Isoxazoles; Oxadiazoles; Oxazoles; Phenylalanine; Phytotherapy; Picornaviridae Infections; Plant Extracts; Plants, Medicinal; Pyrrolidinones; Receptors, Virus; Rhinovirus; Valine; Viral Proteins; Zinc | 2001 |
6 other study(ies) available for pleconaril and rupintrivir
Article | Year |
---|---|
Pharmacophore modeling, docking, and principal component analysis based clustering: combined computer-assisted approaches to identify new inhibitors of the human rhinovirus coat protein.
Topics: Antiviral Agents; Binding Sites; Capsid Proteins; Cell Line; Computer Simulation; Cytopathogenic Effect, Viral; Databases, Factual; Humans; Models, Molecular; Principal Component Analysis; Rhinovirus; Structure-Activity Relationship | 2005 |
An Orally Available 3-Ethoxybenzisoxazole Capsid Binder with Clinical Activity against Human Rhinovirus.
Topics: | 2012 |
A Novel Series of Highly Potent Small Molecule Inhibitors of Rhinovirus Replication.
Topics: Antiviral Agents; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Rhinovirus; Small Molecule Libraries; Structure-Activity Relationship; Thiophenes; Virus Replication | 2017 |
In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses.
Topics: Antiviral Agents; Cell Survival; Cells, Cultured; Common Cold; Humans; Isoxazoles; Oxadiazoles; Oxazoles; Phenylalanine; Pyrrolidinones; Reverse Transcriptase Polymerase Chain Reaction; Rhinovirus; Spectrophotometry; Valine | 2000 |
Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C.
Topics: Antiviral Agents; Common Cold; Dose-Response Relationship, Drug; HeLa Cells; Humans; In Vitro Techniques; Isoxazoles; Oxadiazoles; Oxazoles; Phenylalanine; Piperidines; Pyridazines; Pyrrolidinones; Replicon; Rhinovirus; RNA, Viral; Tubercidin; Valine; Virus Replication | 2014 |
Automated cell-based luminescence assay for profiling antiviral compound activity against enteroviruses.
Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Enterovirus; Enterovirus Infections; HeLa Cells; Humans; Isoxazoles; Luminescent Measurements; Microbial Sensitivity Tests; Oxadiazoles; Oxazoles; Phenylalanine; Pyrrolidinones; Valine; Vero Cells | 2019 |